SuperworthDrugs Made In America Acquisition market cap DMAA
Share price times shares outstanding: what the whole company sells for, since 2025.
- Today, Oct 23, 2026
- $264M
- Highest close in our data
- $357.4M
- May 2026
Drugs Made In America Acquisition is worth $264M at the close on Oct 23, 2026, at $10.88 a share.
That is down 24% over the last year.
Its highest close in our data was $357.4M in May 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $264M | $257.1M | $357.4M | −24% |
| 2025 | $347.6M | $335.8M | $347.6M | n/a |
Against its peers
Companies in Financial Services nearest Drugs Made In America Acquisition's size, closest first, today.
| Company | Market cap |
|---|---|
| DMAADrugs Made In America Acquisition | $264M |
| RMBIRichmond Mutual Bancorporation | $266.5M |
| VABKVirginia National Bankshares | $269.6M |
| NKSHNational Bankshares | $257.9M |
| FXNCFirst National | $271.1M |
| HWBKHawthorn Bancshares | $271.1M |
| EFSIEagle Financial Services | $254M |
| FNRNFirst Northern Community Bancorp | $275.6M |
| GBFHGBank Financial | $252.2M |
| WNEBWestern New England Bancorp | $278.2M |
| SNFCASecurity National Financial | $250.5M |
| Peer median | $268M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Drugs Made In America Acquisition
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.